Robert Couch

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Couch Robert B; Atmar Robert L; Cate Thomas R; Quarles John M; Keitel Wendy A; Arden Nancy H; Wells Janet; Niño Diane; Wyde Philip R
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
Keitel Wendy A; Atmar Robert L; Nino Diane; Cate Thomas R; Couch Robert B
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
Couch Robert B
Seasonal inactivated influenza virus vaccines.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Couch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Couch Robert B; Atmar Robert L; Cate Thomas R; Quarles John M; Keitel Wendy A; Arden Nancy H; Wells Janet; Niño Diane; Wyde Philip R
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
Vaccine 2009;27(39):5344-8.
2008: Keitel Wendy A; Atmar Robert L; Nino Diane; Cate Thomas R; Couch Robert B
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
The Journal of infectious diseases 2008;198(7):1016-8.
2008: Couch Robert B
Seasonal inactivated influenza virus vaccines.
Vaccine 2008;26 Suppl 4():D5-9.
2007: Couch Robert B; Winokur Patricia; Brady Rebecca; Belshe Robert; Chen Wilbur H; Cate Thomas R; Sigurdardottir Bryndis; Hoeper Amy; Graham Irene L; Edelman Robert; He Fenhua; Nino Diane; Capellan Jose; Ruben Frederick L
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
Vaccine 2007;25(44):7656-63.
2007: Atmar Robert L; Keitel Wendy A; Cate Thomas R; Munoz Flor M; Ruben Fred; Couch Robert B
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
Vaccine 2007;25(29):5367-73.
2007: Mbawuike I; Zang Y; Couch R B
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.
Vaccine 2007;25(17):3263-9.
2007: Couch Robert B; Winokur Patricia; Edwards Kathryn M; Black Steven; Atmar Robert L; Stapleton Jack T; Kissner Jennifer M; Shinefield Henry; Denny Thomas N; Bybel Michael J; Newman Frances K; Yan Lihan;
Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses.
The Journal of infectious diseases 2007;195(6):826-32.
2007: Mbawuike Innocent N; Zhang Yongxin; Couch Robert B
Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes.
Respiratory research 2007;8():44.
2006: Safdar Amar; Rodriguez M Alma; Fayad Luis E; Rodriguez Gilhen H; Pro Barbara; Wang Michael; Romaguera Jorge E; Goy Andre H; Hagemeister Fredrick B; McLaughlin Peter; Bodey Gerald P; Kwak Larry W; Raad Issam I; Couch Robert B
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
The Journal of infectious diseases 2006;194(10):1394-7.
2006: Atmar Robert L; Keitel Wendy A; Patel Shital M; Katz Jacqueline M; She Dewei; El Sahly Hana; Pompey Justine; Cate Thomas R; Couch Robert B
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1135-42.
2006: Keitel Wendy A; Atmar Robert L; Cate Thomas R; Petersen Nancy J; Greenberg Stephen B; Ruben Fred; Couch Robert B
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
Archives of internal medicine 2006;166(10):1121-7.
2006: Treanor John J; Schiff Gilbert M; Couch Robert B; Cate Thomas R; Brady Rebecca C; Hay C Mhorag; Wolff Mark; She Dewei; Cox Manon M J
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
The Journal of infectious diseases 2006;193(9):1223-8.
2004: Belshe Robert B; Newman Frances K; Frey Sharon E; Couch Robert B; Treanor John J; Tacket Carol O; Yan Lihan
Dose-dependent neutralizing-antibody responses to vaccinia.
The Journal of infectious diseases 2004;189(3):493-7.
2003: Couch R B
Challenge studies.
Developments in biologicals 2003;115():119-21.
2003: Couch R B
An overview of serum antibody responses to influenza virus antigens.
Developments in biologicals 2003;115():25-30.
2002: Frey Sharon E; Couch Robert B; Tacket Carol O; Treanor John J; Wolff Mark; Newman Frances K; Atmar Robert L; Edelman Robert; Nolan Carrie M; Belshe Robert B;
Clinical responses to undiluted and diluted smallpox vaccine.
The New England journal of medicine 2002;346(17):1265-74.
2001: Schmidt A C; Couch R B; Galasso G J; Hayden F G; Mills J; Murphy B R; Chanock R M
Current research on respiratory viral infections: Third International Symposium.
Antiviral research 2001;50(3):157-96.
2001: Keitel W A; Cate T R; Nino D; Huggins L L; Six H R; Quarles J M; Couch R B
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
The Journal of infectious diseases 2001;183(2):329-332.
2000: Couch R B
Influenza: prospects for control.
Annals of internal medicine 2000;133(12):992-8.
2000: Couch R B
Prevention and treatment of influenza.
The New England journal of medicine 2000;343(24):1778-87.
2000: Munoz F M; Galasso G J; Gwaltney J M; Hayden F G; Murphy B; Webster R; Wright P; Couch R B
Current research on influenza and other respiratory viruses: II international symposium.
Antiviral research 2000;46(2):91-124.
1999: Mbawuike I N; Fujihashi K; DiFabio S; Kawabata S; McGhee J R; Couch R B; Kiyono H
Human interleukin-12 enhances interferon-gamma-producing influenza-specific memory CD8+ cytotoxic T lymphocytes.
The Journal of infectious diseases 1999;180(5):1477-86.
1999: Ghosh S; Champlin R; Couch R; Englund J; Raad I; Malik S; Luna M; Whimbey E
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):528-32.
1999: Kaiser L; Couch R B; Galasso G J; Glezen W P; Webster R G; Wright P F; Hayden F G
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998.
Antiviral research 1999;42(3):149-75.
1999: Couch R B
Measures for control of influenza.
PharmacoEconomics 1999;16 Suppl 1():41-5.
1997: Couch R B; Keitel W A; Cate T R
Improvement of inactivated influenza virus vaccines.
The Journal of infectious diseases 1997;176 Suppl 1():S38-44.
1997: Keitel W A; Cate T R; Couch R B; Huggins L L; Hess K R
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
Vaccine 1997;15(10):1114-22.
1997: Yousuf H M; Englund J; Couch R; Rolston K; Luna M; Goodrich J; Lewis V; Mirza N Q; Andreeff M; Koller C; Elting L; Bodey G P; Whimbey E
Influenza among hospitalized adults with leukemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(6):1095-9.
1997: Whimbey E; Englund J A; Couch R B
Community respiratory virus infections in immunocompromised patients with cancer.
The American journal of medicine 1997;102(3A):10-8; discussion 25-6.
1997: Couch R B; Englund J A; Whimbey E
Respiratory viral infections in immunocompetent and immunocompromised persons.
The American journal of medicine 1997;102(3A):2-9; discussion 25-6.
1997: Mbawuike I N; Acuna C L; Walz K C; Atmar R L; Greenberg S B; Couch R B
Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12.
Mechanisms of ageing and development 1997;94(1-3):25-39.
1996: Lewis V A; Champlin R; Englund J; Couch R; Goodrich J M; Rolston K; Przepiorka D; Mirza N Q; Yousuf H M; Luna M; Bodey G P; Whimbey E
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(5):1033-7.
1996: Mbawuike I N; Piedra P A; Cate T R; Couch R B
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
Journal of medical virology 1996;50(2):105-11.
1996: Keitel W A; Cate T R; Atmar R L; Turner C S; Nino D; Dukes C M; Six H R; Couch R B
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
Clinical and diagnostic laboratory immunology 1996;3(5):507-10.
1996: Whimbey E; Champlin R E; Couch R B; Englund J A; Goodrich J M; Raad I; Przepiorka D; Lewis V A; Mirza N; Yousuf H; Tarrand J J; Bodey G P
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(5):778-82.
1995: Kilbourne E D; Couch R B; Kasel J A; Keitel W A; Cate T R; Quarles J H; Grajower B; Pokorny B A; Johansson B E
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
Vaccine 1995;13(18):1799-803.
1995: Whimbey E; Couch R B; Englund J A; Andreeff M; Goodrich J M; Raad I I; Lewis V; Mirza N; Luna M A; Baxter B
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(2):376-9.
1995: Atmar R L; Keitel W A; Cate T R; Quarles J M; Couch R B
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
The Journal of infectious diseases 1995;172(1):253-7.
1995: Elting L S; Whimbey E; Lo W; Couch R; Andreeff M; Bodey G P
Epidemiology of influenza A virus infection in patients with acute or chronic leukemia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1995;3(3):198-202.
1995: Kimberlin D W; Couch R B; Galasso G J; Richman D D; Whitley R J
Research initiatives in studies of antiviral resistance and consensus points and recommendations.
Antiviral research 1995;26(4):439-52.
1994: Mbawuike I N; Dillion S B; Demuth S G; Jones C S; Cate T R; Couch R B
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
Vaccine 1994;12(14):1340-8.
1994: Keitel W A; Couch R B; Cate T R; Hess K R; Baxter B; Quarles J M; Atmar R L; Six H R
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
Journal of clinical microbiology 1994;32(10):2468-73.
1994: Gill E P; Dominguez E A; Greenberg S B; Atmar R L; Hogue B G; Baxter B D; Couch R B
Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness.
Journal of clinical microbiology 1994;32(10):2372-6.
1994: Whimbey E; Elting L S; Couch R B; Lo W; Williams L; Champlin R E; Bodey G P
Influenza A virus infections among hospitalized adult bone marrow transplant recipients.
Bone marrow transplantation 1994;13(4):437-40.
1994: Keitel W A; Couch R B; Cate T R; Maassab H F
Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.
The Journal of infectious diseases 1994;169(2):477.
1994: Di Fabio S; Mbawuike I N; Kiyono H; Fujihashi K; Couch R B; McGhee J R
Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells.
International immunology 1994;6(1):11-9.
1993: Lo W; Whimbey E; Elting L; Couch R; Cabanillas F; Bodey G
Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(10):778-82.
1993: Dominguez E A; Taber L H; Couch R B
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children.
Journal of clinical microbiology 1993;31(9):2286-90.
1993: Couch R B
Advances in influenza virus vaccine research.
Annals of the New York Academy of Sciences 1993;685():803-12.
1993: Keitel W A; Couch R B; Quarles J M; Cate T R; Baxter B; Maassab H F
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
The Journal of infectious diseases 1993;167(2):305-11.
1993: Mbawuike I N; Lange A R; Couch R B
Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons.
Viral immunology 1993;6(1):55-64.
1991: Glezen W P; Keitel W A; Taber L H; Piedra P A; Clover R D; Couch R B
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.
American journal of epidemiology 1991;133(3):296-304.
1991: Clover R D; Crawford S; Glezen W P; Taber L H; Matson C C; Couch R B
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.
The Journal of infectious diseases 1991;163(2):300-4.
1990: Atmar R L; Greenberg S B; Quarles J M; Wilson S Z; Tyler B; Feldman S; Couch R B
Safety and pharmacokinetics of rimantadine small-particle aerosol.
Antimicrobial agents and chemotherapy 1990;34(11):2228-33.
1990: Atmar R L; Bloom K; Keitel W; Couch R B; Greenberg S B
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults.
Vaccine 1990;8(3):217-24.
1990: Gruber W C; Taber L H; Glezen W P; Clover R D; Abell T D; Demmler R W; Couch R B
Live attenuated and inactivated influenza vaccine in school-age children.
American journal of diseases of children (1960) 1990;144(5):595-600.
1990: Mbawuike I N; Six H R; Cate T R; Couch R B
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
Journal of virology 1990;64(3):1370-4.
1990: Keitel W A; Couch R B; Cate T R; Six H R; Baxter B D
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
The Journal of infectious diseases 1990;161(1):22-6.
1988: Crawford S A; Clover R D; Abell T D; Ramsey C N; Glezen P; Couch R B
Rimantadine prophylaxis in children: a follow-up study.
The Pediatric infectious disease journal 1988;7(6):379-83.
1988: Keitel W A; Cate T R; Couch R B
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
American journal of epidemiology 1988;127(2):353-64.
1987: Zahradnik J M; Couch R B; Gerin J L
Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology.
The Journal of infectious diseases 1987;155(5):903-8.
1986: Clover R D; Crawford S A; Abell T D; Ramsey C N; Glezen W P; Couch R B
Effectiveness of rimantadine prophylaxis of children within families.
American journal of diseases of children (1960) 1986;140(7):706-9.
1986: Couch R B; Kasel J A; Glezen W P; Cate T R; Six H R; Taber L H; Frank A L; Greenberg S B; Zahradnik J M; Keitel W A
Influenza: its control in persons and populations.
The Journal of infectious diseases 1986;153(3):431-40.
1985: Gilbert B E; Wilson S Z; Knight V; Couch R B; Quarles J M; Dure L; Hayes N; Willis G
Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.
Antimicrobial agents and chemotherapy 1985;27(3):309-13.
1984: Dacso C C; Couch R B; Six H R; Young J F; Quarles J M; Kasel J A
Sporadic occurrence of zoonotic swine influenza virus infections.
Journal of clinical microbiology 1984;20(4):833-5.
1984: Wilson S Z; Gilbert B E; Quarles J M; Knight V; McClung H W; Moore R V; Couch R B
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.
Antimicrobial agents and chemotherapy 1984;26(2):200-3.
1984: Samo T C; Greenberg S B; Palmer J M; Couch R B; Harmon M W; Johnson P E
Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose.
The Journal of infectious diseases 1984;150(2):181-8.
1983: Six H R; Webster R G; Kendal A P; Glezen W P; Griffis C; Couch R B
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons.
Infection and immunity 1983;42(2):453-8.
1983: Couch R B; Cate T R
Managing influenza in older patients.
Geriatrics 1983;38(9):61-3, 67, 71-4.
1983: Samo T C; Greenberg S B; Couch R B; Quarles J; Johnson P E; Hook S; Harmon M W
Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.
The Journal of infectious diseases 1983;148(3):535-42.
1983: Cate T R; Couch R B; Parker D; Baxter B
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.
Reviews of infectious diseases 1983;5(4):737-47.
1983: Velazco J G; Couch R B; Six H R; Glezen W P
Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains.
Bulletin of the World Health Organization 1983;61(2):345-52.
1983: McClung H W; Knight V; Gilbert B E; Wilson S Z; Quarles J M; Couch R B; Divine G W; Gordon W H; Thurston J M; Atmar R L
Ribavirin aerosol treatment of influenza B virus infection.
Transactions of the Association of American Physicians 1983;96():284-93.
1982: Cate T R; Couch R B
Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
Infection and immunity 1982;38(1):141-6.
1982: Glezen W P; Couch R B; Six H R
The influenza herald wave.
American journal of epidemiology 1982;116(4):589-98.
1982: Greenberg S B; Harmon M W; Couch R B; Johnson P E; Wilson S Z; Dacso C C; Bloom K; Quarles J
Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus.
The Journal of infectious diseases 1982;145(4):542-6.
1981: Anderson P; Insel R A; Smith D H; Cate T R; Couch R B; Glezen W P
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults.
The Journal of infectious diseases 1981;144(6):530-8.
1981: Galegov G A; Knight V; Pushkarskaia N L; Wilson S Z; Couch R B
[Combined action of remantadine (amantadine) and ribavirin on experimental influenza]
Voprosy virusologii 1981;(6):697-701.
1981: Knight V; McClung H W; Wilson S Z; Waters B K; Quarles J M; Cameron R W; Greggs S E; Zerwas J M; Couch R B
Ribavirin small-particle aerosol treatment of influenza.
Lancet 1981;2(8253):945-9.
1981: Quarles J M; Couch R B; Cate T R; Goswick C B
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
Antiviral research 1981;1(3):149-55.
1981: Cate T R; Couch R B
Lack of effect of influenza virus infection on induction and expression of delayed hypersensitivity.
The Journal of infectious diseases 1981;144(3):280.
1981: Martin R R; Couch R B; Greenberg S B; Cate T R; Warr G A
Effects of infection with influenza virus on the function of polymorphonuclear leukocytes.
The Journal of infectious diseases 1981;144(3):279-80.
1980: Murphy B R; Rennels M B; Douglas R G; Betts R F; Couch R B; Cate T R; Chanock R M; Kendal A P; Maassab H F; Suwanagool S; Sotman S B; Cisneros L A; Anthony W C; Nalin D R; Levine M M
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
Infection and immunity 1980;29(2):348-55.
1980: Wilson S Z; Knight V; Wyde P R; Drake S; Couch R B
Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice.
Antimicrobial agents and chemotherapy 1980;17(4):642-8.
1980: Murphy B R; Markoff L J; Chanock R M; Spring S B; Maassab H F; Kendal A P; Cox N J; Levine M M; Douglas R G; Betts R F; Couch R B; Cate T R
Genetic approaches to attenuation of influenza A viruses for man.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1980;288(1029):401-15.
1980: Glezen W P; Couch R B; Taber L H; Paredes A; Allison J E; Frank A L; Aldridge C
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977.
American journal of epidemiology 1980;111(1):13-22.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Robert Couch

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Procedures

Geographic Areas

Phenomena

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Robert Couch (preview)

All Publications